Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2008
12/11/2008WO2008151110A2 Molecular diagnosis and typing of lung cancer variants
12/11/2008WO2008151089A2 Fluorescent phospholipase a2 indicators
12/11/2008WO2008151072A1 Multigene prognostic assay for lung cancer
12/11/2008WO2008151035A2 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds)
12/11/2008WO2008151032A2 Arrays and methods comprising m. smithii gene products
12/11/2008WO2008151031A1 Detecting mutated gene sequences by mutant-enriched sequencing
12/11/2008WO2008151023A2 Methods and compositions for multiple displacement amplification of nucleic acids
12/11/2008WO2008151004A1 A genetic lesion associated with cancer
12/11/2008WO2008150964A1 Methods and kits for diagnosing and treating acute joint injury
12/11/2008WO2008150962A2 Method to predict or diagnose a gastrointestinal disorder or disease
12/11/2008WO2008150937A2 Real-time pcr
12/11/2008WO2008150884A1 Methods and compositions related to riboswitches that control alternative splicing and rna processing
12/11/2008WO2008150873A1 Ultrasensitive detection of biomolecules using immunoseparation and diffractometry
12/11/2008WO2008150841A1 Compositions and methods for binding lysophosphatidic acid
12/11/2008WO2008150838A1 Improved miniprep system for simple and rapid plasmid dna extraction
12/11/2008WO2008150515A1 A method for testing or screening protein synthesis inhibitors
12/11/2008WO2008150512A2 Methods for identifying an increased likelihood of recurrence of breast cancer
12/11/2008WO2008150491A2 BIOMARKERS PREDICTIVE OF THE RESPONSIVENESS TO TNFα INHIBITORS IN AUTOIMMUNE DISORDERS
12/11/2008WO2008150461A2 High throughput screening of genetically modified photosynthetic organisms
12/11/2008WO2008150436A1 Analyte determination methods and devices
12/11/2008WO2008150432A1 System and meth0d for identification of individual samples from a multiplex mixture
12/11/2008WO2008150377A1 High throughput mutation screening methods and kits
12/11/2008WO2008150276A2 Virus coated nanoparticles and uses thereof
12/11/2008WO2008150186A1 A screening method for compounds that reduce er stress
12/11/2008WO2008150158A1 Novel plant virus designated tomato marchitez virus
12/11/2008WO2008150031A1 Inhibitor of biosynthesis of plant hormone auxin, chemical plant regulator comprising the inhibitor as active ingredient, herbicidal agent, and use thereof
12/11/2008WO2008150025A1 Novel bone mass increasing agent
12/11/2008WO2008150010A1 SCREENING METHOD UTILIZING NOVEL SUBSTRATE EphA4 FOR Ϝ-SECRETASE
12/11/2008WO2008149976A1 Cardiac reentry model chip and apparatus and method for evaluating drug using the cardiac reentry model chip
12/11/2008WO2008149855A1 Method of amplifying methylated nucleic acid or unmethylated nucleic acid
12/11/2008WO2008149809A1 Cell chip for evaluation of cellular motility
12/11/2008WO2008149807A1 Method for induction of differentiation of es cell
12/11/2008WO2008149803A1 Method of sorting and identifying cancer stem cells in acute lymphocytic leukemia using surface antigen markers
12/11/2008WO2008149797A1 Apparatus for concentrating dielectric microparticles
12/11/2008WO2008149782A1 Prognostic factor in sarcoma, and metastasis inhibitor
12/11/2008WO2008149636A1 Method for counting colonies
12/11/2008WO2008149346A2 Enhanced sensitivity polymerase chain reactions
12/11/2008WO2008149247A2 Kinetic determination of peracid and/or peroxide concentrations
12/11/2008WO2008149237A2 Method for methylation analysis
12/11/2008WO2008148972A2 Reaction medium for identifying/detecting micro-organisms
12/11/2008WO2008148921A1 Method of analysis of relationship in the species solea senegalensis
12/11/2008WO2008148862A1 Methods and materials related to hair pigmentation and cancer
12/11/2008WO2008148858A1 The novel adipocytokine visfatin/pbef1 is an apoptosis associated factor induced in monocytes during in vivo hiv-1 infection
12/11/2008WO2008148723A1 Hydrophilic coating paint
12/11/2008WO2008148522A2 Method to identify modulators of b-raf protein kinase and their use for the treatment of anxiety and depression
12/11/2008WO2008148392A1 Enzyme activity assay using rolling circle amplification
12/11/2008WO2008148216A1 Drak2 expression is associated with diabetes
12/11/2008WO2008148215A1 Estrogen receptor-related receptor gamma (err gamma) in bone and cartilage formation and methods and compositions relating to same
12/11/2008WO2008148193A1 Fhl1 mutations associated with novel x-linked muscular myopathies
12/11/2008WO2008148161A1 In situ methods for gene mapping and haplotyping
12/11/2008WO2008148159A1 Epigenetic methods
12/11/2008WO2008148143A1 Diagnostics in a monoplex/multiplex format
12/11/2008WO2008128198A3 Dna methylation analysis by digital bisulfite genomic sequencing and digital methylight
12/11/2008WO2008127213A3 Methods, systems, and software for regulated oligonucleotide-mediated recombination
12/11/2008WO2008125738A3 A method for selecting responders to blockade of integrin receptors
12/11/2008WO2008124109A3 System for pulling out regulatory elements using yeast
12/11/2008WO2008122673A3 Human diabetes susceptibility tnfrsf10a gene
12/11/2008WO2008122670A3 Human diabetes susceptibility tnfrsf10b gene
12/11/2008WO2008119539A3 Modified polynucleotides comprising ribose rings
12/11/2008WO2008118843A3 Arrays, systems, and methods of using genetics predictors of polycystic diseases
12/11/2008WO2008118415A3 Genetic polymorphisms associated with coronary events and drug response
12/11/2008WO2008114282A3 Transgenic rice (oryza sativa) comprising pe-7 event and method of detection thereof
12/11/2008WO2008112990A3 Methods of diagnosis and treatment of crohn's disease
12/11/2008WO2008112903A3 Genetic alterations on chromosome 16 and methods of use thereof for the diagnosis and treatment of type 1 diabetes
12/11/2008WO2008112754A3 Methods, computer-accessible medium, and systems for generating a genome wide haplotype sequence
12/11/2008WO2008111063A3 Regulation of neurotransmitters sequestration and release through manipulation of the vesicular functions
12/11/2008WO2008109432A3 Therapeutic targeting of interleukins using sirna in neutral liposomes
12/11/2008WO2008109110A3 System for regulating blood pressure
12/11/2008WO2008103299A3 Methods and compositions for prognosing, detecting, and treating age-related macular degeneration
12/11/2008WO2008100352A3 Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis
12/11/2008WO2008095730A3 Method for identifying an active ingredient complex, which modifies an enzymatic property of a synaptosomal / synaptic site of action complex in the region of a synaptosomal / synaptic membrane, biosensor arrangement, device for amperometric and/or potentiometric pharmacological site of action and/or active ingredient testi
12/11/2008WO2008092094A3 Method and materials for detection, diagnosis and management of ovarian cancer
12/11/2008WO2008091364A3 Nanoparticles as tags for bioanalyte detection by nuclear magnetic resonance or electron spin resonance
12/11/2008WO2008088855A3 Gene polymorphisms as predictors of tumor progression and their use in cancer therapy
12/11/2008WO2008088747A3 Method of monitoring hiv infection
12/11/2008WO2008088694A3 Regulation of lipid droplet formation by modulation of fit1 and fit2 and uses thereof
12/11/2008WO2008086322A3 Method for estimating melting temperature of a nucleic acid in buffers containing divalent ions
12/11/2008WO2008086182A3 Use of gene signatures to design novel cancer treatment regimens
12/11/2008WO2008085990A3 Systems for genome selection
12/11/2008WO2008085777A9 A method for early detection of cancer
12/11/2008WO2008083390A3 Dual-functional nonfouling surfaces and materials
12/11/2008WO2008079303A3 Detection of organ rejection
12/11/2008WO2008079185A3 Pesticide biomarker
12/11/2008WO2008076788A3 Optimized pan-her ligands
12/11/2008WO2008076434A3 Predicting a response to risperidone
12/11/2008WO2008073890A3 Buffer composition
12/11/2008WO2008073629A3 Bifunctional predictors of cancer treatment sensitivity and resistance
12/11/2008WO2008073607A3 A method for estimating error from a small number of expression samples
12/11/2008WO2008073165A8 Methods and compositions for identifying anti-hcv agents
12/11/2008WO2008069975A3 Methods of using f-spondin as a biomarker for cartilage degenerative conditions
12/11/2008WO2008069973A3 Four-color dna sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators
12/11/2008WO2008069884A3 Two-stage nucleic acid amplification using an amplification oligomer
12/11/2008WO2008067551A3 Genetic analysis systems and methods
12/11/2008WO2008066878A3 Methods and products for diagnosing cancer
12/11/2008WO2008066858A3 Method of separating target dna from mixed dna
12/11/2008WO2008066769A3 Genetic diagnosis of depression
12/11/2008WO2008060618A3 Use of genetic determinants in cardiovascular risk assessment
12/11/2008WO2008054828A3 Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma
12/11/2008WO2008054534A3 Screening systems utilizing rtp801
12/11/2008WO2008048639A3 Genetic prediction of schizophrenia susceptibility